umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Phase 2 open-label extension study (ole) of patisiran, an investigational sIRNA investigational agent for familial amyloid polyneuropathy (fap)
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
Show others and affiliations
2015 (English)In: Journal of the peripheral nervous system, ISSN 1085-9489, E-ISSN 1529-8027, Vol. 20, no 2, p. 117-118Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2015. Vol. 20, no 2, p. 117-118
National Category
Neurology
Identifiers
URN: urn:nbn:se:umu:diva-109467ISI: 000360214600083OAI: oai:DiVA.org:umu-109467DiVA, id: diva2:859037
Conference
Biennial Meeting of the Peripheral-Nerve-Society, JUN 27-JUL 02, 2015, Quebec, CANADA
Available from: 2015-10-05 Created: 2015-09-28 Last updated: 2018-03-16Bibliographically approved

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Suhr, Ole
By organisation
Medicine
In the same journal
Journal of the peripheral nervous system
Neurology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 64 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf